Source: Annual Congress 2002 - Bench to bedside in lung injury



Rating:

Share or cite this content

Citations should be made in the following way:
F. P. A. Villani, A. Anichini, E. Bajetta, M. Del Vecchio, M. Vitali (Milan, Italy). Cardiac and respiratory effects of immunotherapy with R-Interleukin-12. Eur Respir J 2002; 20: Suppl. 38, 1806

Member's Comments

No comment yet.

Related content which might interest you: Allergen immunotherapy in paediatric respiratory disease Source: Annual Congress 2008 - MP10 - Allergen immunotherapy in paediatric respiratory disease Year: 2008 Effect of pulmonary rehabilitation on cardiac output responses during exercise in COPD Source: Annual Congress 2012 - The best posters in pulmonary rehabilitation and chronic care Year: 2012 Inhaled beta-agonist does not modify sympathetic activity in patients with COPD Source: International Congress 2014 – Multidimensional analysis of respiratory problems Year: 2014 Cardiac function during COPD exacerbations assessed by cardiac MRI Source: International Congress 2019 – Imaging of airway diseases Year: 2019 Pulmonary hemodynamics and respiratory function associations in children with bronchial asthma Source: International Congress 2016 – Living with asthma around the globe Year: 2016 Possible amiodarone toxicity and lung function test in infants with cardiac arrhythmia Source: Eur Respir J 2005; 26: Suppl. 49, 676s Year: 2005 The impact of systemic corticosteroids on respiratory muscle function in severe asthma Source: Eur Respir J 2005; 26: Suppl. 49, 505s Year: 2005 Recruitment maneuvers in the presence of pulmonary hypertension: Cardiorespiratory effects during experimental acute lung injury Source: International Congress 2014 – Pathophysiological mechanisms at different scales Year: 2014 Early corticosteroid treatment in ARDS: late effects on respiratory mechanics and tissue remodelling Source: Eur Respir J 2002; 20: Suppl. 38, 36s Year: 2002 Non-invasive respiratory strategies in acute respiratory failure Source: International Congress 2018 – State of the art session: Respiratory critical care Year: 2018 Pulmonary and hemodynamic responses to fructose-1,6-diphosphate in patients with acute respiratory failure Source: Eur Respir J 2005; 26: Suppl. 49, 557s Year: 2005 Targeted therapy in respiratory disease Source: Breathe, 17 (4) 210170; 10.1183/20734735.0170-2021 Year: 2021 Cardiac biomarkers and outcomes of COPD exacerbations Source: International Congress 2019 – Airway disease-associated exacerbations Year: 2019 Small airway dysfunction is associated to the excessive bronchoconstriction in asthma Source: International Congress 2014 – Lung function testing: new findings and new approaches Year: 2014 Anti-inflammatory effects of targeted lung denervation in patients with COPD Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases Year: 2014 Role of aerosolized therapy in the incidence of cardiac rythm disturbances in patients hospitalized with a COPD exacerbation Source: Virtual Congress 2020 – Prognosis and integrated management of COPD Year: 2020 Peculiarities of antibacterial therapy of respiratory infections in patients with bronchial asthma Source: Eur Respir J 2004; 24: Suppl. 48, 639s Year: 2004 Monitoring of lung function in non-invasive respiratory support Source: Research Seminar 2009 - The rationale and use of surfactant and continuous positive airway pressure (CPAP) in extremely low gestational age neonates (ELGANs) Year: 2009 Physiological rationale of noninvasive mechanical ventilation use in acute respiratory failure Source: Eur Respir Mon; 2008: 41: 3–23 Year: 2008 Cardiovascular effects of innovative therapies in lung cancer Source: Eur Respir Monogr 2020; 88: 154-166 Year: 2020